Source: International Congress 2019 – Interstitial lung disease registries
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Puglisi (Forlì, Italy), S. Tomassetti (Forlì, Italy), M. Bosi (Forlì, Italy), C. Ravaglia (Forlì, Italy), A. Arcadu (Forlì, Italy), A. Caringella (Acquaviva delle Fonti, Italy), L. Bivona (Caltanisetta, Italy), M. Marchi (Forlì, Italy), A. Mendez (Vila Nova de Gaia, Portugal), F. Carrico (Guarda, Portugal), C. Gurioli (Forlì, Italy), L. Donati (Forlì, Italy), S. Piciucchi (Forlì, Italy), A. Dubini (Forlì, Italy), V. Poletti (Aarhus, Denmark). Clinical meaning of IPAF in a real-life cohort of IPF patients. 4714

Member's Comments

No comment yet.

Related content which might interest you: Clinical description of a population of Dutch IPF patients Source: Annual Congress 2008 - Management of idiopathic pulmonary fibrosis: what can we learn from the pathophysiology? Year: 2008 Clinical and inflammatory characteristics of patients with COPD in primary care: an observational study Source: International Congress 2017 – Markers of COPD progression Year: 2017 Clinical course of IPF Italian patients during 12-month of observation: results from the FIBRONET observational study Source: International Congress 2019 – Interstitial lung disease registries Year: 2019 PROOF: A prospective observational registry to describe the disease course and outcomes of idiopathic pulmonary fibrosis patients in a real-world clinical setting in Belgium and Luxembourg: Exposure in the interim report of 175 IPF patients Source: International Congress 2016 – IPF clinical Year: 2016 Clinical spectrum and outcome of non IPF patients with a typical UIP picture Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases Year: 2021 Clinical and biological characteristics of the French COBRA cohort of adult subjects with asthma Source: Eur Respir J, 50 (2) 1700019; 10.1183/13993003.00019-2017 Year: 2017 Characteristics of patients receiving mepolizumab in real-world practice –REALITI-A study Source: International Congress 2018 – New developments in the treatment of asthma Year: 2018 Clinical characteristics and outcomes in hospitalized COVID-19 patients with COPD Source: Virtual Congress 2021 – COVID-19 and obstructive diseases: risk factors, management and long-term effects Year: 2021 Phenotypes related with clinical improvement of omalizumab-treated patients in routine clinical practice. FENOMA Study Source: International Congress 2017 – Techniques to treat asthma Year: 2017 Efficacy and safety of pirfenidone in patients with IPF. A single center real-life experience. Source: International Congress 2017 – Idiopathic pulmonary fibrosis: from the bench to the bedside Year: 2017 Real-world exacerbation rates in Japanese patients with COPD: results from the EXACOS observational cohort study Source: Virtual Congress 2021 – Biomarkers to phenotype COPD: prediction of exacerbations Year: 2021 Clinical, radiological and functional outcomes in patients with COVID-19 pneumonia: A prospective observational study Source: Virtual Congress 2021 – Imaging in COVID-19 Year: 2021 Dual bronchodilation in real-life COPD management: analysis of patients’ characteristics enrolled in COPD Registry in Russia Source: Virtual Congress 2020 – Pharmacological management of COPD Year: 2020 Risk of future exacerbations among COPD patients – a real-world register-based cohort study (AvoidEx) Source: Virtual Congress 2020 – Airflow obstruction, COPD and comorbidities Year: 2020 Healthy survivor bias in patients with idiopathic pulmonary fibrosis in clinical registries. Source: Virtual Congress 2021 – News in treatment and diagnosis of idiopathic interstitial pneumonia Year: 2021 PROOF-registry: A prospective observational registry to describe the disease course and outcomes of IPF patients in a real-world clinical setting- An interim report Source: International Congress 2015 – IPF: clinical aspects Year: 2015 Biomarker measurement in asthma patients receiving biologic therapy: a real-world retrospective study Source: International Congress 2018 – Eosinophils in airway disease Year: 2018 Persistence of clinical criteria of chronic bronchitis in patients with COPD over time: A longitudinal analysis of the TRACE cohort. Source: International Congress 2017 – Markers of COPD progression Year: 2017 Clinical characteristics and determinants of exacerbation in Japanese patients with COPD: Hokkaido COPD cohort study results Source: Annual Congress 2012 - COPD exacerbation Year: 2012 Baseline characteristics and survival of patients with idiopathic pulmonary fibrosis (IPF): analysis from the Swedish IPF registry Source: Virtual Congress 2020 – Real life in the field of idiopathic pulmonary fibrosis: treatments and registries Year: 2020